Evidence map›Paper›PMID 36542671›Full record

Trial reportPloS one2022

BEATVIC, a body-oriented resilience therapy for individuals with psychosis: Short term results of a multi-center RCT.

Elisabeth C D van der Stouwe, Bertine de Vries, Laura A Steenhuis, Clement O Waarheid, Remon Jans, Steven de Jong, André Aleman, Gerdina H M Pijnenborg, Jooske T Van Busschbach

Open access · goldAbstract readRandomized Controlled TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Elisabeth C D van der StouweRob Giel Onderzoekcentrum, University Center of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Bertine de VriesDepartment of Clinical Neuropsychology, Faculty of Behavioural and Social Sciences, University of Groningen, Groningen, The Netherlands.
Laura A SteenhuisDepartment of Clinical Neuropsychology, Faculty of Behavioural and Social Sciences, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-1256-3754
Clement O WaarheidDepartment of Psychotic Disorders, GGZ Drenthe, Assen, The Netherlands.
Remon JansDepartment of Psychotic Disorders, GGZ Drenthe, Assen, The Netherlands.
Steven de JongLentis Psychiatric Institute, Lentis Research, Groningen, The Netherlands.
André AlemanDepartment of Neuroscience, University Medical Center Groningen, Cognitive Neuroscience Center, University of Groningen, Groningen, The Netherlands.
Gerdina H M PijnenborgDepartment of Clinical Neuropsychology, Faculty of Behavioural and Social Sciences, University of Groningen, Groningen, The Netherlands.
Jooske T Van BusschbachRob Giel Onderzoekcentrum, University Center of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
University Medical Center Groningen · NLUniversity of Groningen · NLGGZ Drenthe · NLLentis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndividuals with a psychotic disorder are at an increased risk of victimization, but evidenced-based interventions are lacking.

aimsA body-oriented resilience therapy ('BEATVIC') aimed at preventing victimization was developed and its effectiveness was assessed in a multicenter randomized controlled trial.

methods105 people with a psychotic disorder were recruited from six mental health centers. Participants were randomly allocated to 20 BEATVIC group sessions (n = 53) or befriending group sessions (n = 52). Short term effects on risk factors for victimization (e.g. social cognitive deficits, inadequate interpersonal behavior, low self-esteem, internalized stigma, aggression regulation problems), physical fitness and secondary outcomes were expected. At six-month follow-up, the effect on victimization (either a 50% reduction or an absence of victimization incidents) was examined.

resultsIntervention-dropout was 28.30% for BEATVIC and 39.62% for befriending. In both conditions the majority of participants (60.5% BEATVIC vs 62.9% befriending) showed a reduction or absence of victimization incidents at six months follow-up, which was not significantly different according to condition. Multilevel analyses revealed no main effect of time and no significant time x group interaction on other outcome measures. Per protocol analyses (participants attending ≥ 75% of the sessions) did not change these results.

conclusionsAlthough a reduction or absence of victimization was found at short term follow-up for the majority of participants, BEATVIC was not more effective than the active control condition. No short-term additional effects on risk factors of victimization were found. Analysis of the data at 2-year follow-up is warranted to investigate possible effects in the long-term. TRIAL REGISTRATION NUMBER: Current Controlled Trials: ISRCTN21423535.

Indexed as

BullyingCrime VictimsPsychotic DisordersAggressionHumansSocial Stigma

Identifiers

PMID36542671
PMCPMC9770373
OpenAlexW4312060007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.